Dr. Siwei Li, Director of DMPK at Degron Therapeutics. Dr. Li earned his B.S. in Biotechnology from Nanjing University in 2008 and received his Ph.D. in Chemistry from the University of Cincinnati (USA) in 2014. Then he served as postdoctoral research fellow at the University of Michigan College of Pharmacy and also obtained a professional certificate in Data Science from Stanford University. With over 10 years of experience in drug discovery and development, Dr. Li has held key positions including Director of AI Pharmacology at an AI Drug Discovery biotech company, Senior Principal Investigator at BeiGene, and Research Scientist at a Silicon Valley precision medicine company. He is also recognized as an Elsevier Outstanding Reviewer for Food Chemistry journal. His research focuses on small molecule non-clinical pharmacokinetics, Model-Informed Drug Discovery (MIDD): PKPD and AI model development and application in drug discovery and development, Bioanalytical technology development and application, AI-driven proteomics and metabolomics research. Dr. Li has contributed to 10+ drug discovery programs and led/participated in non-clinical PK studies supporting multiple China-US IND filings. To date, he has published over 20 papers in internationally renowned journals and filed 1 patent application.
李四维博士，达歌生物药代动力学总监。2008年毕业于南京大学生物技术专业本科，2014年获美国辛辛那提大学化学博士学位。随后在美国密西根大学药学院从事博士后研究，并获斯坦福大学数据科学职业认证。李博士拥有10余年的药物研发经验，曾先后担任AI制药公司AI药理总监、百济神州高级主任研究员及美国硅谷精准医学公司研究科学家。同时，他还是爱思唯尔《Food Chemistry》期刊的杰出审稿人。李博士的研究方向聚焦于小分子非临床药代动力学研究；模型引导的药物研发(MIDD): PKPD模型和AI模型在药物研发中开发和应用；生物分析技术开发与应用。他还在AI赋能蛋白质组学及代谢组学研究方向拥有多年实践经验。曾参与10余个新药研发项目，并主导参与多个中美IND申报相关的非临床药代动力学研究工作。迄今在国际知名期刊发表论文20余篇及申请专利1项。
Megan Qin has over 15 years of experience in the healthcare industry and is a PMI-certified Project Management Professional specializing in clinical research project management, clinical pathway planning, clinical operations, and innovative intelligent solutions. She has held positions at world-renowned healthcare companies including Roche Medical, Bard Medical (BD), BI (Boehringer Ingelheim), and Stryker Neurovascular, where she served as the Head of Clinical Affairs for China, accumulating extensive knowledge and hands-on experience in GCP (Good Clinical Practice) for drugs and medical devices. She is particularly passionate about innovative medical devices, optimizing clinical data applications, and implementing project management risk controls.
Currently, she also holds roles as Committee Member of Medical Device Clinical Trial Quality Management Committee-China Association of Rehabilitation of Disabled Persons and Working Group Member of DIA Real-World Evidence Research Group.
秦飞拥有超过15年的医疗行业经验，PMI认证项目管理专家，专注于临床研究领域项目管理，临床路径规划，临床运营及创新智能化解决方案。她曾就职于罗氏制药、巴德医疗（碧迪医疗）、BI(勃林格殷格翰)以及史赛克医疗等世界知名医疗企业，曾担任中国区临床事务负责人，积累了丰富的药物及医疗器械GCP的知识和实践经验，在创新医疗器械、优化临床数据的应用，实施项目管理风险管控等方面尤其热衷。现兼任中国残疾人康复协会-医疗器械临床试验质量管理专业委员会委员，DIA真实世界研究工作组成员。
Limin Guan has 17 years of experience in the pharmaceutical industry, beginning with technical roles in drug substance process development within a pilot plant setting. Over the past 10 years, he has honed his expertise in clinical supply chain management, starting his journey at Novartis. His professional background includes integrating global supply chain experience across the US, EU, APAC, and beyond, through roles at Novartis, Zailab, Beigene, and Takeda, with a particular focus on the Asia-Pacific region. Currently, Limin provides leadership and strategic direction for Clinical Supply Chain activities in China and the APAC region. His responsibilities include overseeing outsourced operations, serving as the Global Clinical Supply Chain representative to local functions, and advancing capabilities in project planning and execution.
管利民在制药行业拥有17年的经验，最初从事药物原料工艺开发的技术工作，主要集中在中试车间领域。在过去的10年里，他在临床供应链管理方面积累了丰富的经验，并从诺华开始了这一领域的职业旅程。他的职业背景包括在诺华、再鼎、百济和武田公司等担任职务，整合了在美国、欧洲、亚太地区及其他地区的全球供应链经验，尤其专注于亚太区域。目前，他负责领导和制定中国及亚太地区临床供应链活动的战略方向。他的职责涵盖监督外包业务，作为武田全球临床供应链与当地职能部门之间的代表，并推动项目规划与执行能力的提升。
Andy is an accomplished technology leader with over 25 years of experience delivering cutting-edge IT solutions to the accountancy sector. Driven by a passion for transforming business performance through intelligent systems, he founded FD Intelligence in 2020 to pioneer the use of AI in automating tax and accounting processes.
Under Andy’s leadership, FD Intelligence has become a recognised innovator in the UK’s Intelligent Automation space – developing AI-powered solutions that streamline routine, high-volume tasks and unlock real-time efficiency gains. The companies technology enables clients to shift focus from manual processing to high-value strategic work, accelerating both productivity and profitability.
“Tessa Lai—Director, CSC Logistics APAC Warehouse & Distribution Operations Tessa has 15+ years’ experience in clinical supply including supply planning, manufacture, packaging, importation, logistic management and comparator sourcing. As the clinical supply Chain Logistic Asian Director, she manages all APAC clinical supply warehouses and logistic activities, oversees the clinical supply in China (mainland, Hong Kong, Taiwan), Japan, Korea, Australia, India and other Asian countries. Her team also manages APAC local comparator sourcing and related packaging and labelling.”
“赖会明——CSC物流亚太区仓储与配送运营总监 赖会明在临床供应领域拥有超过15年的丰富经验，涵盖供应计划、生产、包装、进口、物流管理及对照药采购等全流程。 作为临床供应链物流亚洲区总监，她全面负责亚太地区所有临床供应仓库及物流运营管理，监管中国（大陆、香港、台湾）、日本、韩国、澳大利亚、印度及其他亚洲国家/地区的临床物资供应。其团队还主导亚太本土对照药采购及相关的包装标签业务。”
Winner of CEO Asia Awards, a visionary achiever and inspirational leader, with excellent track record in strategic planning and international business development.
MBA with distinction, thought leader, with proven ability to create synergies through collaborations, to build competitive edge by leading multi-cultural teams.
I started at 19 in the fresh produce industry as a QA Manager and worked my way up to Technical manager when I was in my early 20’s. A few years later, I took the plunge into interim consultancy. For 10 years I worked in ~25 sites across the UK, predominantly in high care environments from sandwiches, ready meals, prepared salads, cooked meats, party foods and well as other low risk industries like confectionery, canning, exotic fruits and blending. I’ve also enjoyed auditing all over the world, from all over the UK and Ireland, to the EU and as far as Australia. Starting at Bulk in 2023, I was ready to pour all my experience and knowledge into one business, leading a team of technical excellence, with a strong commercial attitude.
As Morison Global’s CEO, Ryan leads the implementation and ongoing development of our strategy focusing on delivering measurable benefits to our members and supporting members in their development and growth. He has over 20 years of expertise in firm strategy, commerciality, and driving sustainable growth having worked for a number of global accounting firms and networks. Ryan has as LLB (Hons) Law degree as well as a certificate in Leading Professional Service Firms from the Harvard Business School.
